Marabio Systems, which developed the first blood test to detect a biological subtype of autism in mothers, recently announced it raised $19m in a series A funding round led by MAK Capital One, LLC.
The northern California-based company plans to use the proceeds to develop a precision immunology platform to diagnose autism and initial...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?